Next-generation gene-editing technology may be able to treat genetic blood disorders such as sickle cell disease, scientists say.
A research team comprised of scientists from Carnegie Mellon University and Yale University successfully tested the gene-editing system on mice in a study published in the journal Nature Communications. The system used in the experiment builds on current gene-editing technology such as clustered regulary interspaced short palindromic repeats, or CRISPR.
Read Full Article »